The studies of Bhattacharya et al. suggest that age-related post-translational modifications of p53 limit its binding to its inhibitor MDM2, thereby activating caspase 3, inducing apoptosis, and thus triggering the pathogenesis that could lead to AMD. This evidence concerns the gene CASP3 and age-related macular degeneration.